| 2022 |
HDAC1 (and HDAC2/3) are histone delactylases: they cleave ε-N-L-lactyllysine (K(L-la)) and K(D-la) marks from histones in vitro, and de-L-lactylase activity of HDAC1 was confirmed in cells. HDAC1-3 also remove diverse short-chain acyl modifications beyond acetyl groups. |
In vitro enzymatic screen with zinc- and NAD-dependent HDACs; cellular validation of de-L-lactylase activity |
Science advances |
High |
35044827
|
| 2023 |
HDAC1/2/3 (class I HDACs) are the primary histone desuccinylases: inhibition or depletion of HDAC1/2/3 markedly increases global histone succinylation, while ectopic expression of catalytically active HDAC1/2/3 reduces it. Reconstituted HDAC1/2/3 complexes show robust desuccinylase activity in vitro. Histone succinylation is enriched at gene promoters and positively correlates with transcriptional activity. |
In vitro desuccinylase assay with reconstituted complexes; gain- and loss-of-function cell experiments; active-site mutant controls; genomic landscape analysis (ChIP-seq) |
Cell discovery |
High |
37580347
|
| 2013 |
FUS directly interacts with HDAC1 (co-immunoprecipitation). This FUS–HDAC1 interaction is required for proper DNA double-strand break (DSB) damage response signaling and repair in neurons. ALS-associated FUS mutants show diminished interaction with HDAC1 and are defective in DNA damage response. |
Co-immunoprecipitation; recruitment of FUS to DSB sites; analysis of familial ALS FUS mutants; DNA damage assays in neurons and ALS patient tissue |
Nature neuroscience |
High |
24036913
|
| 2006 |
HDAC1 serves as a coactivator for the glucocorticoid receptor (GR). A subfraction of HDAC1 becomes acetylated after GR association; acetylation of HDAC1 inactivates its deacetylase activity in vitro, and mutation of the critical acetylation sites abrogates HDAC1 function in vivo. HDAC1 on transcriptionally active chromatin shows low acetylation, while repressed chromatin-associated HDAC1 is highly acetylated. |
In vitro deacetylase activity assay of purified acetylated HDAC1; site-directed mutagenesis of acetylation sites; chromatin immunoprecipitation; in vivo reporter assays |
Molecular cell |
High |
16762839
|
| 2013 |
Protein kinase CK2 phosphorylates HDAC1 and HDAC2 during mitosis, which is required for dissociation of the HDAC1/HDAC2 heterodimer. During metaphase, HDAC1 and HDAC2 dissociate from each other but each remains associated with corepressor complex components (Sin3, NuRD, CoREST) as homodimers. Enzymatic inhibition studies and mutational analyses confirmed that CK2-catalyzed phosphorylation is crucial for this dissociation. |
Kinase inhibition studies; site-directed mutagenesis of phosphorylation sites; co-immunoprecipitation during mitosis; cell fractionation |
The Journal of biological chemistry |
High |
23612983
|
| 2025 |
UM171 acts as a molecular glue that induces high-affinity interaction between KBTBD4 (a CRL3 E3 ligase substrate receptor) and HDAC1/2, targeting HDAC1/2 for degradation within the LSD1-CoREST corepressor complex. Cryo-EM revealed an asymmetric assembly where a single UM171 molecule enables one KBTBD4 KELCH-repeat propeller to engage the HDAC1 catalytic domain (partially masking its active-site rim) while a second propeller strengthens binding cooperatively. Endogenous inositol hexakisphosphate acts as a second molecular glue stabilizing the interaction. Base editor scanning of KBTBD4 and HDAC1 confirmed the functional relevance of these interfaces. |
Cryo-EM structure determination; proteomics; chemical inhibitor studies; base editor scanning mutagenesis; co-immunoprecipitation |
Nature |
High |
39939761
|
| 2018 |
HDAC1/2 suppress expression of PPP2R3A/PR130, a regulatory subunit of the trimeric serine/threonine phosphatase PP2A. This suppression sustains phosphorylation of checkpoint kinases ATM, CHK1, CHK2, as well as WEE1 and CDK1, during replicative stress. PR130 promotes dephosphorylation of ATM by PP2A; genetic elimination of PR130 altered S-phase checkpoint and DNA damage response. |
Genetic elimination of HDAC1/2 and PR130; kinase activity assays; checkpoint phosphorylation analysis; homologous recombination assays |
Nature communications |
High |
29472538
|
| 2021 |
EGFR phosphorylates HDAC1 at tyrosine 72 (Tyr72), which is necessary for HDAC1 protein stability. This EGFR-mediated tyrosine phosphorylation mediates HDAC1's anti-apoptotic function. Prior work had established serine phosphorylation by CK2 promotes HDAC1 deacetylase activity; the EGFR pathway represents an alternative, distinct regulatory mechanism. |
Site-directed mutagenesis of Tyr72; EGFR activity modulation; apoptosis assays; protein stability measurements |
Cell death & disease |
Medium |
33976119
|
| 2017 |
USP19, a deubiquitinase, physically interacts with HDAC1/2 and specifically regulates their K63-linked ubiquitination. USP19 translocates to the nucleus upon ionizing radiation and its activity is required for proper DNA damage response. Loss of USP19 leads to genomic instability through impaired HDAC1/2-dependent DNA damage repair. |
Co-immunoprecipitation; K63-linked ubiquitination assay; nuclear translocation by imaging; DNA damage assays after IR |
Oncotarget |
Medium |
27517492
|
| 2018 |
HDAC1 substrate profiling using a mutant-trapping strategy combined with mass spectrometry identified CDK1, AIFM1, MSH6, and RuvB-like 1 as HDAC1 substrates, revealing roles of HDAC1 beyond histone deacetylation. |
Proteomics-based substrate trapping using catalytically inactive HDAC1 mutant combined with mass spectrometry |
ACS chemical biology |
Medium |
30421914
|
| 2016 |
Acetylation of HDAC1 (via acetyltransferases) attenuates HDAC1 activity and trans-represses HDAC2 activity through HDAC1/HDAC2 dimerization, converting the corepressor complex into an activator complex during erythropoiesis. During erythropoiesis, global HDAC activity is dramatically reduced, linked to HDAC1 acetylation. |
Biochemical analysis of HDAC1 acetylation; dimerization studies; HDAC activity assays during erythroid differentiation |
International journal of molecular sciences |
Medium |
33187090
|
| 2008 |
Atrophin (Drosophila)/RERE (vertebrate) recruits HDAC1/2 through its ELM2-SANT domains to form a complex with histone methyltransferase G9a. This complex co-occupies chromosomal loci in Drosophila to establish H3K9 methylation and gene repression, controlling wing vein and melanotic-mass cell fate decisions. |
Co-immunoprecipitation; chromosomal co-localization; Drosophila genetic interaction studies; histone modification assays |
EMBO reports |
Medium |
18451879
|
| 2012 |
Ets-1 transcription factor physically interacts with HDAC1 and co-expression of Ets-1 with HDAC1 synergistically represses IL-10 transcription in Th1 cells. Loss of Ets-1 reduces HDAC1 enrichment at Il10 regulatory regions with concomitant increased histone H3 acetylation. |
Co-immunoprecipitation; chromatin immunoprecipitation; luciferase reporter assay; Ets-1 knockout cells |
Journal of immunology |
Medium |
22266280
|
| 2021 |
BAP1 forms a trimeric protein complex with HMGB1 and HDAC1 that modulates HMGB1 acetylation and its secretion. Reduced BAP1 levels cause increased ubiquitylation and degradation of HDAC1, leading to increased acetylation of HMGB1 and its active secretion, which promotes mesothelial cell transformation. |
Co-immunoprecipitation; ubiquitylation assays; HMGB1 acetylation measurement; cell transformation assays; patient serum analysis |
Proceedings of the National Academy of Sciences of the United States of America |
Medium |
34815344
|
| 2023 |
ENO2-derived phosphoenolpyruvate (PEP) selectively inhibits HDAC1 activity, increasing acetylation of β-catenin and activating the Wnt/β-catenin pathway in colorectal cancer cells. This identifies PEP as an endogenous metabolite inhibitor of HDAC1. |
In vitro HDAC1 enzymatic activity assay with PEP; β-catenin acetylation measurement; pathway activation assays; xenograft models |
Nature metabolism |
Medium |
37667133
|
| 2025 |
TRIM46 is a ubiquitin E3 ligase that targets HDAC1 for ubiquitination and proteasomal degradation. The TRIM46–HDAC1 axis regulates genes involved in DNA replication and repair, and TRIM46 overexpression promotes breast cancer cell proliferation and chemoresistance. |
Co-immunoprecipitation; ubiquitination assay; CRISPR/Cas9 homologous recombination to recreate SNP; in vitro and in vivo proliferation/chemoresistance assays |
The EMBO journal |
Medium |
34459501
|
| 2014 |
HDAC1 is sufficient to activate FoxO transcription factors and induce muscle fiber atrophy in vivo, requiring its deacetylase activity. This involves deacetylation of FoxO3a and induction of atrophy genes including atrogin-1. Dominant-negative HDAC1 (deacetylase-dead) blocked these effects, establishing deacetylase activity as mechanistically required. |
In vivo expression of wild-type and dominant-negative HDAC1 plasmids; FoxO acetylation and activity assays; gene expression analysis; muscle fiber size measurements |
Journal of cell science |
Medium |
24463822
|
| 2023 |
HDAC1 and HDAC2 are synthetically lethal with each other when one paralog is hemizygously deleted (collateral synthetic lethality). Mechanistically, targeted degradation of HDAC2 in HDAC1-deficient neuroblastoma cells promotes degradation of NuRD complex subunits, diminishes chromatin accessibility at HDAC2-NuRD-bound sites, and impairs enhancer-associated transcription. |
dTAG-mediated protein degradation; genetic disruption; ATAC-seq; ChIP-seq; in vitro and in vivo tumor growth assays |
Nature structural & molecular biology |
High |
37488358
|
| 2025 |
Rapid HDAC1 degradation (via dTAG within 1 hour) in mouse ESCs lacking HDAC2 revealed that H2BK5 and H2BK11 are the most sensitive substrates for HDAC1. Upregulated genes showed increased H2BK5ac and H3K27ac at their TSS. Paradoxically, the most strongly downregulated genes showed decreased acetylation and chromatin accessibility at super-enhancers, demonstrating that HDAC1 is required to maintain histone acetylation at critical enhancer regions for the pluripotency gene network. |
dTAG rapid degradation system (<1 hour); histone acetylation mass spectrometry; RNA-seq time course; ATAC-seq; H3K27ac ChIP-seq |
Nucleic acids research |
High |
39704107
|
| 2004 |
Recombinant HDAC1 expressed in mammalian cells is only active as a multi-protein complex; the purified His-tagged HDAC1 preparation co-purifies with endogenous HDAC2 and HDAC3, demonstrating that HDAC1 requires complex formation for enzymatic activity. Removal of the His-tag increased activity 2–4 fold. |
Stable expression of His-tagged HDAC1 in mammalian cells; nickel affinity purification; Western blot identification of co-purifying HDACs; deacetylase activity assay |
Life sciences |
Medium |
15043985
|
| 2017 |
The ELM2 domain of MIER1 and MIER2 (but not MIER3) is required for HDAC1 recruitment. MIER2, but not MIER3, co-immunoprecipitates with HDAC1 in a cell-line-dependent manner, and MIER2 complexes have associated deacetylase activity. A conserved tryptophan residue (W228) in the ELM2 domain is critical for HDAC1 recruitment. |
Co-immunoprecipitation; deacetylase activity assay; deletion analysis; site-directed mutagenesis of ELM2 domain |
PloS one |
Medium |
28046085
|
| 2022 |
HDAC1 deacetylates JAK1 at lysine 1109; HDAC1 inhibition by SAHA increases JAK1 acetylation at K1109, promoting its proteasomal degradation and reducing STAT3-driven FGL1 transcription. This was established by co-immunoprecipitation showing HDAC1 as an essential deacetylase of JAK1, and by mass spectrometry identification of the specific acetylation site. |
Co-immunoprecipitation; mass spectrometry identifying JAK1 K1109 acetylation; proteasomal degradation assay; ChIP for STAT3 at FGL1 promoter; RNA-seq |
Journal for immunotherapy of cancer |
Medium |
39384195
|
| 2025 |
HDAC1 K412 lactylation is essential for regulation of ferroptosis resistance in colorectal cancer. HDAC inhibitors (SAHA and TSA) specifically diminish HDAC1 K412 lactylation, leading to increased H3K27 acetylation of FTO and ALKBH5, activation of these m6A erasers, reduced m6A modification of FSP1 mRNA, and its degradation, sensitizing cells to ferroptosis. |
Drug screening; mass spectrometry identification of HDAC1 K412 lactylation; ChIP for H3K27ac at FTO/ALKBH5; m6A quantification; in vivo xenograft models |
Advanced science |
Medium |
39888307
|
| 2016 |
HDAC1 and HDAC2 directly bind to the TP53 gene locus (demonstrated by ChIP) and contribute to maintaining mutant p53 expression in pancreatic cancer. MYC also directly binds the TP53 locus, and MYC recruitment drops upon HDAC inhibitor treatment, suggesting a class I HDAC-MYC cooperative mechanism at the TP53 gene. |
Chromatin immunoprecipitation (ChIP) for HDAC1, HDAC2, and MYC at TP53 gene; genetic siRNA knockdown; HDAC inhibitor treatment; RT-PCR and Western blot for mutant p53 |
Oncogene |
Medium |
27721407
|
| 2022 |
Inflammation-driven NF-κB signaling recruits HDAC1 (and HDAC3) to the antioxidant response element (ARE) in the Slc40a1 (ferroportin) promoter in macrophages. HDAC1 and HDAC3 recruitment is dependent on NF-κB signaling and leads to repression of ferroportin transcription, contributing to anemia of inflammation. |
Chromatin immunoprecipitation (ChIP) for HDAC1/3 at Slc40a1 ARE; pharmacological and targeted RNAi screens; NF-κB signaling inhibition |
Blood |
Medium |
39656097
|
| 2011 |
In Schwann cells, HDAC1 controls Schwann cell survival by regulating levels of active β-catenin, while HDAC2 (not HDAC1) activates the transcriptional program of myelination in synergy with Sox10. These represent distinct, non-redundant primary functions of the two paralogs in peripheral nervous system myelination. |
Conditional mouse genetics (Schwann cell-specific ablation of Hdac1 and Hdac2); expression analysis of Sox10, Krox20; β-catenin activity measurement; histological analysis of sciatic nerves |
Nature neuroscience |
High |
21423190
|
| 2010 |
HDAC1 and HDAC2 directly mediate the repressive transcriptional functions of p63 in epidermal progenitor cells: HDACs bind and are active at promoters of p63-repressed targets (p21, 14-3-3σ, p16/INK4a) in normal keratinocytes. Loss of both HDAC1 and HDAC2 leads to increased acetylation of p53, which opposes p63 functions, and p53 is required for HDAC inhibitor-mediated p21 expression. |
Conditional ectodermal knockout of Hdac1/2; ChIP for HDAC binding at target promoters; p53 acetylation measurement; p53 genetic requirement analysis in keratinocytes |
Developmental cell |
High |
21093383
|
| 2016 |
HDAC1 (and HDAC2) regulate global poly(A) RNA stability at the post-transcriptional level. Inhibition of HDAC1/2 induces widespread degradation of normally stable poly(A) RNA in mammalian and Drosophila cells. The mechanism involves CBP/p300-mediated acetylation of CAF1a (a catalytic subunit of the CCR4-CAF1-NOT deadenylase complex), which accelerates poly(A) RNA degradation. |
HDAC1/2 inhibition and knockdown; RNA stability assays; acetylation of CAF1a demonstrated; adipocyte differentiation model |
Molecular cell |
Medium |
27635759
|
| 2019 |
HDAC1 regulates β-cell proliferation by deacetylating histones at the Cdkn1b/p27 locus, thereby reducing p27 expression and allowing cell cycle progression from G1 to S phase. HDAC1 overexpression increases Cyclin A2, Cyclin B1, and E2F1 expression; overexpression of p27 blocks HDAC1-mediated β-cell proliferation. |
HDAC1 overexpression in primary rat islets and INS-1 cells; p27 overexpression rescue experiment; cell cycle analysis; gene expression analysis |
The Biochemical journal |
Medium |
30322885
|
| 1996 |
The human RPD3L1 gene (HDAC1) was cloned and found to be highly homologous (52% amino acid identity) to the yeast RPD3 transcription factor. The gene encodes a 482 amino acid protein and maps to chromosome band 1p34.1. |
cDNA cloning from human fetal lung library; sequence alignment; FISH chromosomal mapping; Northern blot expression analysis |
Cytogenetics and cell genetics |
High |
8646880
|
| 2014 |
HDAC1 and Klf4 competitively bind to the promoter region of Klf4, with HDAC1 repressing Klf4 expression in myeloid leukemia. HDAC1 knockdown increases Klf4 expression and inhibits cell cycle progression; Klf4 overexpression can block the pro-proliferative effects of HDAC1 overexpression, and vice versa, establishing a mechanistic interplay. |
ChIP for HDAC1 and Klf4 at Klf4 promoter; knockdown and overexpression of HDAC1 and Klf4; rescue experiments in leukemia cell lines and in vivo |
Cell death & disease |
Medium |
25341045
|
| 2021 |
HDAC1 (but not HDAC2) controls the transcriptional identity and survival of glioma stem cells in a p53-dependent manner; HDAC1 loss is not compensated by HDAC2 in this context (unlike in normal neural stem cells). Knockdown of HDAC1 suppresses tumor growth in patient-derived xenograft models. |
shRNA knockdown of HDAC1 and HDAC2; cell-based and biochemical assays; RNA-seq; patient-derived xenograft models; p53 genetic manipulation |
JCI insight |
Medium |
34494550
|
| 2023 |
HDAC1 inhibits beige adipocyte-mediated thermogenesis by regulating histone crotonylation (H3K18cr) and acetylation (H3K18ac) at the enhancers and promoters of Pgc1α and Ucp1 genes. Deletion of Hdac1 in beige adipocytes increases H3K18cr at these regulatory regions, promoting Pgc1α/Ucp1 transcription and thermogenesis. |
Conditional Hdac1 deletion in beige adipocytes; H3K18cr and H3K18ac ChIP-seq; gene expression analysis; energy expenditure measurement; MS275 HDAC inhibitor treatment |
Cellular signalling |
Medium |
37640195
|
| 2022 |
TNFα + IFNγ stimulation promotes formation of a FRA1:c-JUN:HDAC1 complex at the AP1 response element of the filaggrin (FLG) promoter, which suppresses FLG expression in keratinocytes. Co-immunoprecipitation demonstrated HDAC1 interaction with FRA1:c-JUN; HDAC1 knockdown abrogated cytokine-induced FLG suppression. |
DNA affinity precipitation assay; co-immunoprecipitation; HDAC1 knockdown; luciferase reporter assay; mouse models of skin inflammation |
Proceedings of the National Academy of Sciences of the United States of America |
Medium |
36067301
|
| 2019 |
HDAC1 regulates anti-inflammatory effects of isoflurane in human monocytes by preventing NF-κB nuclear translocation. Co-immunoprecipitation showed that LPS decreased HDAC1/HDAC2 interaction, which was restored by isoflurane pretreatment. Gene silencing of HDAC1 (and HDAC2) blocked isoflurane-induced reduction of NF-κB nuclear translocation and proinflammatory cytokine production. |
Co-immunoprecipitation of HDAC1/2 interaction; siRNA gene silencing; NF-κB nuclear translocation assay; cytokine measurement in THP-1 cells and primary monocytes |
Immunology and cell biology |
Medium |
31950542
|
| 2022 |
DNTTIP1 recruits HDAC1 to the DUSP2 gene promoter, maintaining a deacetylated state of histone H3K27 and suppressing DUSP2 transcription. This leads to aberrant ERK pathway activation and elevated MMP2, promoting nasopharyngeal carcinoma metastasis. |
ChIP assay for HDAC1 at DUSP2 promoter; co-immunoprecipitation of DNTTIP1-HDAC1 interaction; luciferase reporter assays; in vitro and in vivo metastasis assays |
EBioMedicine |
Medium |
35689852
|
| 2017 |
SP1 recruits HDAC1 to the miR-326 gene promoter in osteosarcoma cells, causing histone deacetylation and transcriptional inhibition of miR-326. This was established by ChIP assay and DAPA, and the loss of miR-326 activates the SMO/Hedgehog pathway to promote proliferation and metastasis. |
ChIP assay for SP1/HDAC1 at miR-326 promoter; DNA affinity precipitation assay (DAPA); miR-326 expression after SP1/HDAC1 modulation; in vivo metastasis model |
Journal of cellular and molecular medicine |
Medium |
32743904
|